Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 12, 4420-4424, December 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation
Blood Pallandre et al. 112: 4420

Supplemental materials for: Pallandre et al

Files in this Data Supplement:

  • Figure S1. CX3CL1 prevents KIR activation and SHP-1 recruitment in human peripheral NK cell interactions with autologous mDC (JPG, 74.3 KB) -
    To confirm the role of CX3CL1 on KIR signaling following interactions with their cognate MHC Class I molecules on autologous mDC, human peripheral NK cell subsets were sorted according to KIR2DL1 expression using fluorescence activated cell sorting (with anti-KIR2DL1 clone 143211, R&Dsystems). (A) KIR2DL1+ and KIR2DL1 resting peripheral human NK and HLA-Cw4 mDC were cultured in the presence of CX3CL1-blocking mAb (at a 1:10 DC-NK ratio) in 96- well plates for 24 hours. CCL3 mAb was used as a control. NK-derived IFN-γ production was assessed in culture supernatants. The data represent means of triplicates ± SE. Three independent experiments were performed with similar results. (B) The influence of CX3CL1 in cognate KIR and MHC Class I interactions during DC and NK cell cross-talk was investigated on human peripheral NK cells. KIR2DL1+ and KIR2DL1 resting human NK were incubated with autologous HLA-Cw4 mDC (ratio 2:1) during 0, 3 and 10 minutes at 37°C and immunoprecipitated with protein G beads coated with anti-KIR2DL1 mAb (T-20 clone, Santa-cruz). The immunoprecipitate was run on an SDS-PAGE, transferred to a membrane and then immunoblotted with anti-SHP-1 mAb (upper panel), anti-phosphotyrosine mAb (middle panel) and anti-KIR2DL1 mAb (clone 2F9, Abcam; lower panel). A representative experiment out of three is shown.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020